People · Operator
Named in public records as an officer, director or promoter · active 2015–2023 · Healthtech, Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| G Medical Innovations Holdings Ltd. | — | Healthtech | Series A | $20.6M | $3.3M | 2022 |
| SkinJect, Inc. | — | Biotechnology | Series A | $8.3M | $19.6M | 2015 |
Kenneth Melani at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Kenneth Melani on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Joseph Donnelly | 1 | 4 |
| Chanan Epstein | 1 | 2 |
| Michael Fare | 1 | 2 |
| James Nolan | 1 | 2 |
| David Seligman | 1 | 2 |
| Anthony Florence | 1 | 2 |
| Yeshoshua Jacob Gleitman | 1 | 1 |
| Yacov Geva | 1 | 1 |
| Yehoshua Gleitman | 1 | 1 |
| Brendan De Kauwe | 1 | 1 |
| Kobi Ben-Efraim | 1 | 1 |
| Benny Tal | 1 | 1 |
| Dror Nuriel-Roth | 1 | 1 |
| Zeev Rotstein | 1 | 1 |
| Oded Shahar | 1 | 1 |
| Urs Wettstein | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.